Nucleolin as activator of human papillomavirus type 18 oncogene transcription in cervical cancer

Journal of Experimental Medicine

Volumn 196, Issue 8, 2002, Pages 1067-1078

  Grinstein, Edgar ^a   Wernet, Peter ^a   Snijders, Peter J F ^b   Rösl, Frank ^c   Weinert, Inge ^d   Jia, Wentao ^d   Kraft, Regine ^d   Schewe, Christiane ^e   Schwabe, Michael ^e   Hauptmann, Steffen ^e   Dietel, Manfred ^e   Meijer, Chris J L M ^b   Royer, Hans Dieter ^a,d  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^e HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Carcinogenesis; Cell cycle; Chromatin; Proliferation; Tumor virus

Indexed keywords

CELL PROTEIN; NUCLEOLIN; ONCOPROTEIN;

ARTICLE; CANCER CELL; CARCINOGENESIS; CELL CYCLE S PHASE; CELL PROLIFERATION; CHROMATIN STRUCTURE; CONTROLLED STUDY; ENHANCER REGION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HOST CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; NONHUMAN; ONCOGENE; PHENOTYPE; PRECANCER; PRIORITY JOURNAL; PROTEIN DNA BINDING; UTERINE CERVIX CANCER; VIRUS TYPING; WART VIRUS;

BASE SEQUENCE; CELL DIVISION; FEMALE; HELA CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; ONCOGENE PROTEINS, VIRAL; ONCOGENES; PAPILLOMAVIRIDAE; PHOSPHOPROTEINS; RNA-BINDING PROTEINS; UTERINE CERVICAL NEOPLASMS;

EID: 0037152165     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20011053     Document Type: Article

References (62)

1. zur Hausen, H., and E.-M. de Villiers. 1994. Human papillomaviruses. Annu. Rev. Microbiol. 48:427-447.
2. Shah, K.V. 1997. Human papillomaviruses and anogenital cancers. N. Engl. J. Med. 337:1386-1388.
3. Walboomers, J.M., M.V. Jacobs, M.M. Manos, F.X. Bosch, J.A. Kummler, K.V. Shah, P.J. Snijders, J. Peto, C.J. Meijer, and N. Munoz. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189:12-19.
4. Bosch, F.X., M.M. Manos, N. Munoz, M. Sherman, A.M. Jansen, J. Peto, M.H. Shiffman, V. Moreno, R. Kurman, and K.V. Shah. 1995. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. International biological study on cervical cancer (IBSCC) study group. J. Natl. Cancer Inst. 88:1361-1365.
5. Barnes, W., G. Delgado, R.J. Kurman, E.S. Petrilli, D.M. Smith, S. Ahmed, A.T. Lorincz, G.F. Temple, A.B. Jenson, and W.D. Lancaster. 1988. Possible prognostic signficance of human papillomavirus type in cervical cancer. Gynecol. Oncol. 29:267-273.
6. Barnes, W., G. Woodworth, S. Waggoner, M. Stoler, A.B. Jenson, G. Delgado, and J. DiPaolo. 1990. Rapid dysplastic transformation of human genital cells by human papillomavirus type 18. Gynecol. Oncol. 38:343-346.
7. Burger, R.A., B.J. Monk, T. Kurosaki, H. Anton-Culver, S.A. Vasilev, M.L. Berman, and S.P. Wilczynski. 1996. Human papillomavirus type 18: Association with poor prognosis in early stage cervical cancer. J. Natl. Cancer Inst. 88:1361-1365.
8. Schwarz, S.M., J.R. Darling, K.A. Shera, M.M. Madeleine, B. McKnight, D.A. Galloway, P.L. Porter, and J.K. McDougall. 2001. Human papillomavirus and prognosis of invasive cervical cancer: A population-based study. J. Clin. Oncol. 19:1906-1915.
9. Villa, L.L., and R. Schlegel. 1991. Differences in transcriptional activity between HPV-18 and HPV-16 map to the viral LCR-E6-E7 region. Virology. 181:347-377.
10. zur Hausen, H. 2000. Papillomaviruses causing cancer: Evasion from host-cell control in early events in carcinogenesis. J. Natl. Cancer Inst. 92:690-698.
11. Dürst, M., D. Glitz, A. Schneider, and H. zur Hausen. 1992. Human papillomavirus type 16 (HPV16) gene expression and DNA replication in cervical neoplasia: Analysis by in situ hybridisation. Virology. 189:132-140.
12. Stoler, M.H., C.R. Rhodes, A. Whitbeck, S.M. Wolinsky, L.T. Chow, and T.R. Broker. 1992. Human papillomavirus type 16 and 18 gene expression in cervical neoplasias. Hum. Pathol. 23:117-128.
13. Wentzensen, N., R. Ridder, R. Klaes, S. Vinokurova, U. Schaefer, and M.K. Doeberitz. 2002. Characterization of viral-cellular fusion transcripts in a large series of HPV16 and 18 positive anogenital lesions. Oncogene. 21:419-426.
14. Dyson, N., P.M. Howley, K. Münger, and E. Harlow. 1989. The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science. 243:934-937.
15. Münger, K., B.A. Werness, N. Dyson, W.C. Phelps, and P.M. Howley. 1989. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J. 8:4099-4105.
16. Scheffner, M., B.A. Werness, J.M. Huibregtse, A.J. Levine, and P.M. Howley. 1990. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 63:1129-1136.
17. Arbeit, J.M., K. Münger, P.M. Howley, and D. Hanahan. 1994. Progressive squamous epithelial neoplasia in K14-human papillomavirus type 16 transgenic mice. J. Virol. 68:4358-4368.
18. Swift, F.V., K. Bhat, H.B. Younghusband, and H. Hamada. 1987. Characterization of a cell type-specific enhancer found in the human papilloma virus type 18 genome. EMBO J. 6:1339-1344.
19. Offord, E.A., and P. Beard. 1990. A member of the activator 1 family found in keratinocytes but not in fibroblasts required for transcription from a human papillomavirus type 18 promoter. J. Virol. 64:4792-4798.
20. Hoppe-Seyler, F., K. Butz, and H. zur Hausen. 1991. Repression of the human papillomavirus type 18 enhancer by the cellular transcription factor Oct-1. J. Virol. 65:5613-5618.
21. Thierry, F., G. Spyrou, M. Yaniv, and P.M. Howley. 1992. Two AP1 sites binding junB are essential for human papillomavirus type 18 transcription in keratinocytes. J. Virol. 66:3740-3748.
22. Bauknecht, T., P. Angel, H.-D. Royer, and H. zur Hausen. 1992. Identification of a negative regulatory domain in the human papillomavirus type 18 promoter: Interaction with the transcriptional repressor YY1. EMBO J. 11:4607-4617.
23. Yukawa, K., K. Butz, T. Yasui, H. Kikutani, and F. Hoppe-Seyler. 1996. Regulation of papillomavirus transcription by the differentiation-dependent epithelial factor Epoc-1/skn1a. J. Virol. 70:10-16.
24. Parker, J.N., W. Zhao, K.J. Askins, T.R. Broker, and L.T. Chow. 1997. Mutational analyses of differentiation-dependent human papillomavirus type 18 enhancer elements in epithelial raft cultures of neonatal foreskin keratinocytes. Cell Growth Differ. 8:751-762.
25. Mack, D.H., and L.A. Laimins. 1991. A keratinocyte-specific transcription factor, KRF-1, interacts with AP-1 to activate expression of human papillomavirus type 18 in squamous epithelial cells. Proc. Natl. Acad. Sci. USA. 88:9102-9106.
26. Butz, K., and F. Hoppe-Seyler. 1993. Transcriptional control of human papillomavirus (HPV) oncogene expression: Composition of the HPV type 18 upstream regulatory region. J. Virol. 67:6467-6486.
27. Lapeyre, B., H. Bourbon, and F. Amalric. 1987. Nucleolin, the major nucleolar protein of growing eukaryotic cells: An unusual protein structure revealed by the nucleotide sequence. Proc. Natl. Acad. Sci. USA. 84:1472-1476.
28. Srivastava, M., and H.B. Pollard. 1999. Molecular dissection of nucleolin's role in growth and cell proliferation: New insights. FASEB J. 13:1911-1922.
29. Ginisty, H., H. Sicard, B. Roger, and P. Bouvet. 1992. Structure and functions of nucleolin. J. Cell Sci. 112:761-772.
30. Bonnet, H., O. Filhol, I. Truchet, P. Brethenou, C. Cochet, F. Amalric, and G. Bouche. 1996. Fibroblast growth factor-2 binds to the regulatory beta subunit of CK2 and directly stimulates CK2 activity toward nucleolin. J. Biol. Chem. 271:24781-24787.
31. Suzuki, N., H. Matsui, and T. Hosoya. 1985. Effects of androgen and polyamines on the phosphorylation of nucleolar proteins from rat ventral prostates with particular reference to 110-kDa phosphoprotein. J. Biol. Chem. 260:8050-8055.
32. Herblott, S., P. Chastagner, L. Samady, J.L. Moreau, C. Demaison, P. Froussard, X. Liu, J. Bonnet, and J. Theze. 1999. IL-2-dependent expression of genes involved in cytoskeleton organization, oncogene regulation, and transcriptional control. J. Immunol. 162:3280-3288.
33. Grinstein, E., I. Weinert, B. Droese, M. Pagano, and H.-D. Royer. 1996. Cell cycle regulation of nuclear factor p92 DNA-binding activity by novel phase-specific inhibitors. J. Biol. Chem. 271:9215-9222.
34. Kadonaga, J.T. 1991. Purification of sequence-specific binding proteins by DNA affinity chromatography. Methods Enzymol. 208:10-23.
35. Cole, S.T., and O. Danos. 1987. Nucleotide sequence and comparative analysis of the human papillomavirus type 18 genome. Phylogeny of papillomaviruses and repeated structure of the E6 and E7 gene products. J. Mol. Biol. 193:599-608.
36. Rosenfeld, J., J. Capdevielle, J.C. Guillernot, and P. Ferrara. 1992. In-gel digestion of proteins for internal sequence analysis after one- or two-dimensional gel electrophoresis. Anal. Biochem. 203:173-179.
37. Stanbridge, E.J., R.R. Flandermeyer, D.W. Daniels, and W.A. Nelson-Rees. 1981. Specific chromosome loss associated with the expression of tumorigenicity in human cell hybrids. Somatic Cell Genet. 7:699-712.
38. Freedman, R.S., J.M. Bowen, A. Leibovitz, S. Pathak, M.J. Siciliano, H.S. Gallager, and B.C. Giovanella. 1982. Characterization of a cell line (SW756) derived from a human squamous carcinoma of the uterine cervix. In Vitro. 18:719-726.
39. Rösl, F., T. Achtstätter, T. Bauknecht, K.-J. Hutter, G. Futtermann, and H. zur Hausen. 1991. Extinction of the HPV18 upstream regulators region in cervical carcinoma cells after fusion with non-tumorigenic human keratinocytes under non-selective conditions. EMBO J. 10:1337-1345.
40. Srivastava, M., P.J. Fleming, H.B. Pollard, and A.L. Burns. 1989. Cloning and sequencing of human nucleolin cDNA. FEBS Lett. 250:99-105.
41. Chomczynski, P., and N. Sacchi. 1987. Single step method of RNA isolation by acid guanidinium thiocyanate phenolchloroform extraction. Anal. Biochem. 162:156-159.
42. Holm, P.S., S. Bergmann, K. Jürchott, H. Lage, K. Brand, A. Ladhoff, K. Mantwill, D.T. Curiel, M. Dobbelstein, M. Dietel, et al. 2002. YB-1 relocates to the nucleus in adenovirus-infected cells and facilitates viral replication by inducing E2 gene expression through the late E2 promoter. J. Biol. Chem. 277:10427-10434.
43. Dürst, M., L. Gissmann, H. Ikenberg, and H. zur Hausen. 1983. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc. Natl. Acad. Sci. USA. 80:3812-3815.
44. Khandjian, E.W., and C. Meric. 1986. A procedure for Northern blot analysis of native RNA. Anal. Biochem. 15:227-232.
45. Feinberg, A., and B.A. Vogelstein. 1984. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 137:266-267.
46. Hanakahi, L.A., L.A. Dempsey, M.-J. Li, and N. Maizels. 1997. Nucleolin is one component of the B cell-specific transcription factor and switch region binding protein, LR1. Proc. Natl. Acad. Sci. USA. 94:3605-3610.
47. Rösl, F., E.-M. Westphal, and H. zur Hausen. 1989. Chromatin structure and transcriptional regulation of human papillomavirus type 18 DNA in HeLa cells. Mol. Carcinogen. 2:72-80.
48. van den Brule, A.J., R. Pol, N. Fransen-Daalmeijer, L.M. Schouls, C.J. Meijer, and P.J. Snijders. 2002. GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J. Clin. Microbiol. 40:779-787.
49. Bednarek, P.H., B.J. Lee, S. Gandhi, E. Lee, and B. Phillips. 1998. Novel binding sites for regulatory factors in the human papillomavirus type 18 enhancer and promoter identified by in vivo footprinting. Virol. 72:708-716.
50. Roger, B., A. Moisand, F. Amalric, and P. Bouvet. 2002. Repression of RNA polymerase I transcription by nucleolin is independent of the RNA sequence that is transcribed. J. Biol. Chem. 277:10209-10219.
51. Erard, M.S., P. Belenguer, M. Caizergues-Ferrer, A. Pantaloni, and F. Amalric. 1988. A major nucleolar protein, nucleolin, induces chromatin decondensation by binding to histone H1. Eur. J. Biochem. 175:525-530.
52. Gross, D.S., and W.T. Garrard. 1988. Nuclease hypersensitive sites in chromatin. Annu. Rev. Biochem. 57:159-197.
53. Boukamp, P., R.T. Petrussevska, D. Breitkreutz, J. Hornung, A. Markham, and N. Fusenig. 1988. Normal keratinisation in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106:761-771.
54. Baker, C.C., W.C. Phelps, V. Lindgren, M.J. Braun, M.A. Gonda, and P.M. Howley. 1987. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J. Virol. 61:962-971.
55. von Knebel Doeberitz, M., T. Oltersdorf, E. Schwarz, and L. Gissmann. 1988. Correlation of modified human papilloma virus early gene expression with altered growth properties in C4-1 cervical carcinoma cells. Cancer Res. 48:3780-3786.
56. Gey, G.O., W.D. Coffman, and M.T. Kubicek. 1952. Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium. Cancer Res. 12:264-265.
57. Peter, M., J. Nakagawa, M. Doree, J.C. Labbe, and E.A. Nigg. 1990. Identification of major nucleolar proteins as candidate mitotic substrates of cdc2 kinase. Cell. 60:791-801.
58. Sarcevic, B., R. Lilischkis, and R.L. Sutherland. 1997. Differential phosphorylation of T-47 human breast cancer cell substrates by D1-, D3-, E-, and A-type cyclin-CDK complexes. J. Biol. Chem. 272:33327-33337.
59. Sailaja, G., R.M. Watts, and H.-U. Bernard. 1999. Many different papillomaviruses have low transcriptional activity in spite of strong epithelial specific enhancers. J. Gen. Virol. 80:1715-1724.
60. Goodwin, E.C., and D. DiMaio. 2000. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways. Proc. Natl. Acad. Sci. USA. 97:12513-12518.
61. Bosch, F.X., E. Schwarz, P. Boukamp, N.E. Fusenig, D. Bartscg, and H. zur Hausen. 1990. Suppression in vivo of human papillomavirus type 18 E6-E7 gene expression in nontumorigenic HeLa x fibroblast hybrid cells. J. Virol. 64:4743-4754.
62. Schwarz, E., U.K. Freese, L. Gissmann, W. Mayer, B. Roggenbuck, A. Stremlau, and H. zur Hausen. 1985. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature. 314:111-114.